Tag: TB-500

Research on TB-500, a synthetic fragment of Thymosin Beta-4 studied for cell migration and angiogenesis.

Posted on by — Leave a comment

Tissue Repair Research Peptides: BPC-157, TB-500, GHK-Cu & IGF-1 LR3 Compared

For research use only. All peptides referenced are research chemicals not approved by the FDA for human use. Not for human consumption.

Tissue Repair Biology: What Researchers Are Studying

Tissue repair and regenerative biology represent some of the most active areas in synthetic peptide research. Multiple compounds have emerged as go-to research tools for studying healing mechanisms, angiogenesis, collagen synthesis, and cellular migration — each targeting distinct biological pathways relevant to musculoskeletal, dermal, vascular, and gastrointestinal tissue repair models. This guide reviews the peptides most commonly used in tissue repair research and what makes each compound uniquely useful.

BPC-157: The Most-Studied Tissue Repair Peptide

BPC-157 (Body Protection Compound-157) has the most extensive preclinical literature of any tissue repair research peptide, with over 100 published studies across tendon, ligament, muscle, gastrointestinal, neurological, and vascular repair models. Its studied mechanisms include FAK-paxillin signaling (critical for cell migration during healing), VEGFR2 upregulation (angiogenesis), and nitric oxide pathway modulation. BPC-157 is particularly valued in musculoskeletal repair research because it appears to exert localized effects at or near the site of administration, making it suitable for targeted tissue studies.

Best suited for: Tendon/ligament repair models, GI biology, neurological signaling, angiogenesis studies

TB-500: Systemic Healing and Cell Migration

TB-500, a synthetic fragment of Thymosin Beta-4 (sequence LKKTETQ), is the most commonly co-studied peptide alongside BPC-157 in tissue repair research. Where BPC-157 research emphasizes localized tissue-level signaling, TB-500 research focuses on systemic cell migration and angiogenesis through its role in actin regulation and progenitor cell activation. Thymosin Beta-4 is one of the most abundant intracellular proteins in eukaryotic cells and is critically involved in G-actin sequestration — the first step in cell motility. TB-500 is studied in cardiac injury models, wound healing, hair follicle biology, and musculoskeletal repair.

Best suited for: Systemic healing models, cardiac biology, angiogenesis, cell migration studies

GHK-Cu: Collagen Synthesis and Extracellular Matrix

GHK-Cu (copper peptide) stands apart from other tissue repair research peptides due to its copper-dependent mechanism and gene expression breadth. Research has shown GHK-Cu activates fibroblast production of collagen types I, II, and III, as well as elastin and proteoglycans — all key extracellular matrix components degraded during tissue damage. Its studied modulation of over 4,000 human genes includes upregulation of wound repair genes and downregulation of inflammatory pathways. GHK-Cu is especially relevant in dermal, connective tissue, and hair follicle repair research.

Best suited for: Skin biology, collagen research, wound healing assays, hair follicle models

IGF-1 LR3: Growth Factor Signaling in Tissue Biology

IGF-1 LR3, the long-acting analogue of insulin-like growth factor 1, is one of the most widely used research reagents in cell proliferation and tissue growth studies. Its extended half-life (due to reduced IGFBP binding) makes it superior to native IGF-1 for experiments requiring sustained PI3K/Akt/mTOR pathway activation. In tissue repair contexts, IGF-1 LR3 is studied in satellite cell activation, muscle fiber hypertrophy models, bone healing, and cartilage synthesis research.

Best suited for: Muscle cell biology, satellite cell studies, bone healing, cartilage research

Comparing Tissue Repair Peptides

PeptidePrimary MechanismEffect PatternTop Research Application
BPC-157FAK-paxillin, NO, VEGFR2LocalizedTendon, GI, neural repair
TB-500Actin/G-actin, cell migrationSystemicCardiac, wound healing, cell migration
GHK-CuCopper-dependent, gene expressionTissue-levelSkin, collagen, ECM research
IGF-1 LR3PI3K/Akt/mTORSystemic/cell-levelMuscle, bone, cartilage

The Wolverine Stack: BPC-157 + TB-500

The combination of BPC-157 and TB-500 has become standard practice in tissue repair research laboratories due to their complementary and non-redundant mechanisms. BPC-157 addresses localized tissue signaling while TB-500 promotes systemic cell migration and vascular support. Researchers reconstitute and administer them separately to maintain individual compound stability and avoid confounding effects. For a detailed protocol overview, see our BPC-157 + TB-500 Research Stack Guide.

Source tissue repair research peptides → Iron Labs Research Catalog

Regulatory Notice

All peptides sold by Iron Labs are research chemicals for laboratory use only. Not approved by the FDA for human or veterinary therapeutic use. Iron Labs makes no health or healing claims. For research purposes only.

Posted on by — Leave a comment

BPC-157 + TB-500: Why Researchers Study This Peptide Combination

For research use only. Neither BPC-157 nor TB-500 are FDA-approved for human use. All content is intended for educational and laboratory research purposes. Not for human consumption.

Overview: Why Researchers Co-Study BPC-157 and TB-500

In preclinical research, BPC-157 and TB-500 have become two of the most co-investigated synthetic peptides due to their complementary biological profiles. Separately, each compound has generated substantial peer-reviewed literature. Together, they are studied in the context of tissue repair biology, angiogenesis, and inflammatory pathway research — making this combination a popular focus for laboratories examining musculoskeletal and wound healing models.

The pairing has become colloquially known in research communities as the “Wolverine Stack,” named for its association with accelerated healing biology in animal models. This article summarizes the scientific rationale for studying these compounds together.

Individual Mechanisms Under Study

BPC-157

Research on BPC-157 has highlighted its interaction with nitric oxide pathways, FAK-paxillin signaling, and VEGFR2 upregulation. In animal models, it has been studied in the context of tendon reattachment, GI tract ulceration, and neural pathway modulation. Its effects in preclinical models appear localized to the site of study.

TB-500

TB-500 is a fragment of Thymosin Beta-4 that influences actin dynamics and cell motility. Research has focused on its role in promoting angiogenesis and progenitor cell activation across broader tissue regions. Its effects in preclinical models appear more systemic compared to BPC-157.

Complementary Research Profiles

Research ParameterBPC-157TB-500
Primary signaling focusNO system, FAK-paxillin, VEGFR2Actin regulation, progenitor cells
Effect distributionLocalized (site-specific)Systemic
GI research modelsExtensive literatureLimited
Cardiac/vascular modelsSome literatureSubstantial literature
Angiogenesis focusModeratePrimary focus area

Laboratory Handling When Studying Both Compounds

Both BPC-157 and TB-500 are supplied as lyophilized powders. Researchers should reconstitute each peptide separately with bacteriostatic water and never combine them in a single vial, as this can compromise stability and confound experimental results. Store reconstituted solutions at 2–8°C and lyophilized stock at -20°C. Strict sterile technique is essential for all preparation steps.

Availability at Iron Labs

Iron Labs supplies both BPC-157 and TB-500 as individual research-grade compounds with third-party COA documentation. We also carry a BPC-157 + TB-500 research blend for laboratories studying these peptides in combination. All products include HPLC purity data and mass spec identity confirmation.

Source BPC-157 and TB-500 for your lab → Iron Labs Research Catalog

Regulatory Notice

BPC-157 and TB-500 are not approved by the FDA for any human or veterinary use. These compounds are sold by Iron Labs strictly as research chemicals for use in laboratory settings. No therapeutic claims are made or implied. This content is for educational purposes only.

Posted on by — Leave a comment

TB-500 Research Overview: Thymosin Beta-4 Fragment in Laboratory Science

For research use only. TB-500 is not approved by the FDA for human use and is sold exclusively as a research chemical. Not for human consumption.

What Is TB-500?

TB-500 is a synthetic peptide derived from the C-terminal region of Thymosin Beta-4 (TB4), a naturally occurring protein found in virtually all human and animal cells. The active fragment studied in most research contexts is the amino acid sequence LKKTETQ. TB-500 has drawn significant scientific interest due to Thymosin Beta-4’s known role in actin regulation, which is fundamental to cell structure and movement.

TB-500 in Preclinical Research

Preclinical literature on TB-500 and its parent molecule Thymosin Beta-4 covers a range of biological phenomena:

  • Cell migration: Thymosin Beta-4 is one of the most abundant intracellular peptides and plays a central role in G-actin sequestration, directly influencing how cells migrate in healing models.
  • Angiogenesis research: Studies have explored TB4’s role in promoting new blood vessel formation, which is relevant to cardiac and wound biology research.
  • Cardiac models: Several peer-reviewed studies examined Thymosin Beta-4 in myocardial infarction animal models, with observations on progenitor cell activation.
  • Inflammation modulation: Laboratory research has examined the compound’s relationship to NF-κB signaling pathways involved in inflammatory cascades.
  • Hair follicle biology: Some research has examined Thymosin Beta-4’s expression in hair follicle stem cell activation models.

Comparison with BPC-157 in Research Contexts

TB-500 and BPC-157 are frequently co-studied in laboratory settings because their proposed mechanisms are complementary. BPC-157 research has focused on localized tissue signaling and GI biology, while TB-500 research has emphasized systemic cell migration and angiogenic pathways. Researchers investigating recovery biology often study both compounds in parallel to examine potential synergistic effects in preclinical models.

Laboratory Handling & Storage

TB-500 is supplied as a lyophilized powder requiring reconstitution with bacteriostatic water. Lyophilized peptide is stable at -20°C for extended periods. Once reconstituted, store at 2–8°C and use within 28 days. As with all research peptides, maintain sterile handling conditions and document all laboratory procedures appropriately.

Purity & COA Documentation

Iron Labs TB-500 is third-party tested with HPLC purity confirmation and mass spectrometry identity verification. COAs are available on each product page for institutional documentation needs.

Regulatory Notice

TB-500 is not FDA-approved for any human or veterinary therapeutic application. It is classified as a research chemical and is sold by Iron Labs exclusively for use in qualified laboratory environments. No health claims are made or implied. This product is not a drug, supplement, or food.

Source TB-500 for your research → View Iron Labs research catalog